S5;E217 David interviews the founders of 2  Life Science portfolio companies that have been around for a while and have made significant progress in their GTM strategies. Both have been previously profiled in detail, Redbud Labs for E138 in Sep24 and Adovate for E184 in Aug25. Thus today’s interviews are updates on the progress they’ve made against their GTM strategies. (recorded 2.18.26)

Follow David on X at https://x.com/DGRollingSouth

Connect On LinkedIn with David at https://www.linkedin.com/in/davidgrisell/

Follow Paul on X at https://x.com/PalmettoAngel

Connect On LinkedIn with Paul at

https://www.linkedin.com/in/paulclarkprivateequity/

We invite your feedback and suggestions at www.ventureinthesouth.com or email [email protected].